What is the management approach for a patient with Acute Respiratory Distress Syndrome (ARDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of ARDS

Implement lung-protective ventilation with tidal volumes of 4-8 mL/kg predicted body weight and plateau pressure ≤30 cmH₂O immediately upon diagnosis, as this is the only intervention proven to reduce mortality across all ARDS severity levels. 1, 2, 3

Core Mechanical Ventilation Strategy (Applies to All ARDS Patients)

Ventilator Settings:

  • Set tidal volume at 4-8 mL/kg predicted body weight (not actual body weight) - this is a strong recommendation suitable as a performance measure 1, 2, 3
  • Maintain plateau pressure ≤30 cmH₂O, ideally ≤28 cmH₂O by performing end-inspiratory pauses of 0.3-0.5 seconds 2, 4, 3
  • Minimize driving pressure (plateau pressure minus PEEP), as this correlates directly with mortality 2
  • Target PaO₂ 70-90 mmHg or SpO₂ 92-97% to avoid oxygen toxicity while ensuring adequate tissue oxygenation 2, 4

PEEP Strategy by Severity:

  • Mild ARDS (PaO₂/FiO₂ 200-300): Use lower PEEP (typically 5-10 cmH₂O), as higher PEEP shows no benefit and potential harm in this population 1, 4
  • Moderate-to-Severe ARDS (PaO₂/FiO₂ <200): Use higher PEEP strategies, titrated to maximal compliance or maximal safe plateau pressure 1, 2
  • Strongly avoid prolonged lung recruitment maneuvers with high PEEP - these cause hemodynamic harm without mortality benefit 1, 3

Severity-Based Adjunctive Therapies

For Severe ARDS (PaO₂/FiO₂ <100 mmHg):

Prone Positioning (Strong Recommendation):

  • Implement prone positioning for >12 hours daily - this is the most effective adjunctive therapy and reduces mortality 1, 2, 3
  • Apply deep sedation and analgesia during prone positioning 3
  • This is a strong recommendation suitable as a performance measure 1

Neuromuscular Blockade (Conditional Recommendation):

  • Consider cisatracurium infusion for 48 hours in early severe ARDS to improve ventilator synchrony and reduce oxygen consumption 1, 2, 3
  • Mortality benefit exists when compared to deep sedation (RR 0.72), but not when compared to light sedation (RR 0.99) 1
  • Benefits include reduced barotrauma (RR 0.55) and possible increase in ventilator-free days 1
  • Risk of ICU-acquired weakness increases (RR 1.16) 1
  • Consider cessation after 48 hours or earlier if rapidly improving 1

Corticosteroids (Conditional Recommendation):

  • Consider corticosteroids when initiated early in the disease course for moderate-to-severe ARDS 1, 2, 3

For Mild ARDS (PaO₂/FiO₂ 200-300 mmHg):

  • Do NOT routinely use prone positioning - this is only indicated for severe ARDS 4
  • Do NOT routinely use neuromuscular blockade - this is only conditionally recommended for early severe ARDS 4
  • Use lower PEEP strategies (5-10 cmH₂O) - avoid applying high PEEP protocols from moderate-severe ARDS 4

Fluid and Hemodynamic Management

  • Implement conservative fluid management strategy once shock is resolved to avoid worsening pulmonary edema 2, 4, 3
  • Monitor right ventricular function with echocardiography to detect acute cor pulmonale, which occurs in 20-25% of ARDS patients 2, 4

Rescue Therapy for Refractory Severe ARDS

VV-ECMO Criteria:

  • Consider VV-ECMO if PaO₂/FiO₂ remains <70 mmHg for ≥3 hours or <100 mmHg for ≥6 hours despite optimized ventilation, prone positioning, and neuromuscular blockade 1, 2, 3
  • Less invasive therapies (lung-protective ventilation, prone positioning, neuromuscular blockade) must be initiated prior to ECMO consideration 1
  • ECMO probably decreases mortality and increases ventilator-free days in severe ARDS 1
  • Consider transfer to ECMO centers when feasible for patients at hospitals without ECMO capabilities 1

Sedation Management

  • Titrate sedation according to protocols with regular drug interruption 2
  • Ensure patient-ventilator synchrony, as even assisted ventilation can induce ventilator-induced lung injury through high tidal volumes 2

Monitoring Requirements

  • Continuously assess PaO₂/FiO₂ ratio to detect progression between ARDS severity categories (mild: 200-300, moderate: 100-200, severe: <100 mmHg) 2, 4, 3
  • Perform serial plateau pressure assessments with end-inspiratory pauses to confirm lung-protective ventilation 2, 4
  • Monitor for auto-PEEP by examining expiratory flow waveforms 4
  • Monitor for ventilator-associated pneumonia, the leading cause of persistent fever in mechanically ventilated patients 4

Supportive Care

  • Elevate head of bed ≥30 degrees to reduce aspiration risk 2, 4
  • Provide stress ulcer prophylaxis and venous thromboembolism prophylaxis 2, 4
  • Initiate early enteral nutrition with formulations containing antioxidants and anti-inflammatory amino acids, which may improve gas exchange 2, 4

Weaning and Liberation

  • Perform daily spontaneous breathing trials (SBT) as the central component of weaning protocol, as this consistently reduces duration of mechanical ventilation 2, 3
  • Use T-piece, CPAP, or low levels of pressure support ventilation for SBT 2

Critical Pitfalls to Avoid

  • Never allow tidal volumes to exceed 8 mL/kg predicted body weight, even if this requires accepting permissive hypercapnia, as ventilator-induced lung injury significantly worsens outcomes 4, 3
  • Never apply high PEEP strategies from moderate-severe ARDS protocols to mild ARDS patients, as this may cause harm without benefit 1, 4
  • Never use prolonged lung recruitment maneuvers with high PEEP - these demonstrate high probability of harm due to hemodynamic effects 1, 3
  • Deleterious clinical response to higher PEEP (worsened oxygenation, dead space, compliance, or hemodynamics) should prompt immediate reevaluation of PEEP level 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ARDS Management in the ICU

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

ARDS Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Mild ARDS Post-Smoke Inhalation Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.